Characterizing and Predicting Drug Effects on Cognition
Phase of Trial: Phase IV
Latest Information Update: 05 Nov 2019
Price : $35 *
At a glance
- Drugs Topiramate (Primary) ; Lorazepam
- Indications Cognition disorders
- Focus Pharmacodynamics; Pharmacokinetics
- Acronyms CPDEC
- 13 Sep 2016 Status changed from recruiting to completed.
- 10 Jan 2014 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
- 17 Aug 2013 New trial record